Long-term Outcomes Following Individualized Primary Tumor Clinical Target Volume Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy
International Journal of Radiation Oncology*Biology*Physics · 2025-05 · 122 (1) · 126-139
DOI: 10.1016/j.ijrobp.2024.12.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025-05. Verfasst von Rui Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sun Yat-sen University Cancer Center; Collaborative Innovation Center for Cancer Medicine; State Key Laboratory of …. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Special Project for Research and Development in Key areas of Guangdong Province, Overseas Expertise Introduction Project for Discipline Innovation.
Abstract (Originalsprache)
PURPOSE: Our institution has developed an individualized elective primary tumor clinical target volume (CTVp) delineation protocol for nasopharyngeal carcinoma (NPC) based on stepwise tumor spread patterns in intensity modulated radiation therapy for over 10 years. Herein, we report the long-term efficacy and toxicities in patients with NPC treated under this protocol. METHODS AND MATERIALS: A total of 7262 patients with histologically proven nonmetastatic NPC treated with intensity modulated radiation therapy following this individualized delineation protocol were retrospectively evaluated. Survival rates were estimated using the Kaplan-Meier method. Dose-volume histogram parameters for patients with local relapse were compared with those of propensity score-matched without local relapse. Dosimetric comparisons of our delineation protocol with the 2018 International Guideline (2018-IG) were conducted on representative early- and advanced-stage NPC cases. RESULTS: The 5-year local relapse-free survival, regional relapse-free survival, distant metastasis-free survival, progression-free survival, and overall survival were 93.6%, 94.4%, 86.8%, 77.8%, and 86.0%, respectively. 92.3% of local relapses and 86.0% of regional relapses occurred within the 95% isodose lines and were considered in-field failures. No significant differences in dose-volume histogram parameters were observed between the local relapse group and the propensity score-matched nonrelapse group. Compared with the 2018-IG, our contouring protocol resulted in a 58.4% and 48.3% reduction in PTV70, and an 80.8% and 62.8% reduction in PTV60 for early and advanced-stage diseases, respectively. Late grade 3 toxicities included ototoxicity (1.8%), xerostomia (0.2%), dysphagia (0.2%), temporal lobe injury (0.2%), and trismus (0.1%). CONCLUSIONS: Individualized elective CTVp delineation based on the stepwise spread patterns of nasopharyngeal carcinoma achieved excellent long-term outcomes and reduced the irradiated volumes at equivalent dose levels compared with the 2018-IG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Sun Yat-sen University Cancer Center; Collaborative Innovation Center for Cancer Medicine; State Key Laboratory of Oncology in South China; Guangdong Key Laboratory of Nasopharyngeal Ca…
Förderung
- National Natural Science Foundation of China
- Special Project for Research and Development in Key areas of Guangdong Province
- Overseas Expertise Introduction Project for Discipline Innovation
- Ministry of Education of the People's Republic of China
- National Key Research and Development Program of China
- Higher Education Discipline Innovation Project
Zitieren
APA
Guo, R., Zhang, W. W., Lv, J., Lin, J. Y., Xu, C., Li, J., Wu, Y. L., Zhang, X. M., Tang, L. L., Sun, Y., & Ma, J. (2025). Long-term Outcomes Following Individualized Primary Tumor Clinical Target Volume Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics, 122(1), 126-139. https://doi.org/10.1016/j.ijrobp.2024.12.006
Vancouver
Guo R, Zhang WW, Lv J, Lin JY, Xu C, Li J, et al. Long-term Outcomes Following Individualized Primary Tumor Clinical Target Volume Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 2025;122(1):126-139. doi:10.1016/j.ijrobp.2024.12.006
BibTeX
@article{Guo2025,
author = {Guo, Rui and Zhang, Wei-Wei and Lv, Jiawei and Lin, Jia-Yi and Xu, Cheng and Li, Jing and Wu, Yan-Ling and Zhang, Xiao-Min and Tang, Ling-Long and Sun, Ying and Ma, Jun},
title = {Long-term Outcomes Following Individualized Primary Tumor Clinical Target Volume Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
volume = {122},
number = {1},
pages = {126--139},
doi = {10.1016/j.ijrobp.2024.12.006}
}
EUVIMED